U.S. Anticoagulant And Antiplatelet Therapies Markets
U.S. Anticoagulant And Antiplatelet Therapies Markets
RELEASE DATE
16-Sep-2002
16-Sep-2002
REGION
North America
North America
Research Code: A281-01-00-00-00
SKU: HC00844-NA-MR_04554
$2,450.00
Special Price $1,837.50 save 25 %
In stock
SKU
HC00844-NA-MR_04554
Description
This report provides revenue forecasts, market shares, projected incidence and prevalence numbers, market and technology trends, and existing and emerging therapeutics. The market is segmented by product class, namely anticoalugants and antiplatelets, each sub-segmented into oral and injection markets. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.
Table of Contents
Executive Summary
- Executive Summary
Overview
- Scope and Segmentation
- Therapeutic Overview
- Disease Overview
- Economic Impact of Cardiovascular Diseases
- Challenges and Strategies
Market Dynamics
- Demand Analysis - I
- Demand Analysis - II
- Market and Technology Trends
- Revenue Forecast
Frost & Sullivan Market Engineering Awards
- Market Engineering Leadership: Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership
- Technology Leadership: Sanofi-Synthelabo
- Business Development Strategy : Aventis Pharmaceuticals
- Technology Innovation: AstraZeneca
- Merger & Acquisition Strategy: Bristol-Myers Squibb
Overview
Competitive Analysis
Oral Anticoagulant Therapies Market
- Introduction
- Market Engineering Analysis
- Revenue Forecast
Injection Anticoagulant Therapies Market
- Competitive Structure
- Market Share Analysis
Overview
Competitive Analysis
Oral Antiplatelet Therapies Market
Injection Antiplatelet Therapies Market
Related Research
Popular Topics
This report provides revenue forecasts, market shares, projected incidence and prevalence numbers, market and technology trends, and existing and emerging therapeutics. The market is segmented by product class, namely anticoalugants and antiplatelets, each sub-segmented into oral and injection markets. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | A281-01-00-00-00 |
Is Prebook | No |